Coral Capital Management LLC

ITEM 5. FEES AND COMPENSATION

A. The specific terms of DNA’s fees and compensation arrangements with respect to the
   Fund are set forth in the Fund’s Offering Documents. The Firm generally charges an
   annual management fee (the “Management Fee”) of between 1.0% and 2.0%,
   depending on the Investor’s Fund and share class. DNA may, in its sole discretion,
   reduce, waive, or rebate the Management Fee with respect to any Investors including,
   without limitation, Investors that are affiliated persons of the Firm.

   Along with the Management Fee, Fund Investors are generally subject to a
   performance- based profit allocation of between 15% - 20%, depending on the Investor’s
   share class, based on the realized and unrealized income and gains of the Fund during its
   fiscal year. The Performance Allocation is due to the General Partner, who has the sole
   discretion to reduce, waive, or rebate Performance Allocation with respect to any
   Investors including, without limitation, Investors that are affiliated persons of DNA.

   SMA fees are negotiated directly with each SMA Investor prior to entering into an
   Investment Management Agreement (“IMA”) with the Investor.

B. DNA generally deducts the Management Fee from the Fund Investors’ accounts
   quarterly in advance, as further disclosed in the Fund’s Offering Documents and
   from SMA Investor’s accounts as outlined in the SMA Investor’s IMA.

C. In addition to the Management Fee and Performance Allocation described above, the
   Funds, as applicable, are responsible for all of their respective initial organizational
   and offering expenses. Also, the Funds are responsible for all of the costs and
   expenses associated with its operations.

D. Clients are expected to pay Management Fees in advance, on a quarterly basis, as
   further disclosed in the Fund’s Offering Documents or SMA’s IMA. No portion of
   the Management Fee will be rebated in the event an Investor makes a withdrawal on a
   day other than the last business day of the calendar quarter.

ITEM 6. PERFORMANCE-BASED COMPENSATION AND SIDE-BY-SIDE MANAGEMENT

As discussed in Item 5 of this Brochure, Clients and SMA Investors are subject to a Performance
Allocation of between 15% - 20% which will be made to the Funds’ General Partner or Firm for
SMA Investors. Although a Performance Allocation generally aligns the Firm’s and its affiliates’
interests with those of Clients, since it is based on both realized and unrealized gains and losses, in
can also create an incentive for DNA to cause Clients to make investments which may be riskier
or more speculative than those which would be made under a different fee arrangement. To
address such potential conflicts of interest, DNA is committed to performing extensive due
diligence on each investment it makes and discloses information about the Clients’ investments
through quarterly reports and other Investor notices and/or presentations. Allocations are charged
in accordance with Rule 205-3 of the Advisers Act, whereby each Investor that is charged the
Performance Allocation must be a “Qualified Client.”

This performance-based compensation generally is calculated and payable annually as of
December 31st of each year, upon liquidation of a Client account, or upon withdrawal by an
Investor of all or part of its investment in such SMA or Client account.

Conflicts of Interest Related to Performance-Based Compensation and Varying Fee
Rates.

The Firm and/or its affiliates, including the General Partner, receive performance- based
compensation as described above. Performance-based compensation creates certain inherent
conflicts of interest with respect to the management of assets. Specifically, the Firm’s and its
affiliates’ entitlement to performance-based compensation may create an incentive for the Firm
and its affiliates to take risks in managing assets that they would not otherwise take in the absence
of performance-based compensation.

As of the date hereof, the Firm’s investment advisory services are expected to be provided to
Clients. However, the Firm may provide investment advisory services to other clients in the
future, including other funds and/or separately managed accounts, which may have the same or
different fee structures as the Clients. This would give rise to a potential conflict of interest, since
the Firm may have an incentive to favor certain clients that pay higher amounts of performance-
based or other compensation to the Firm and/or its affiliates over other clients that pay lower
amounts of such compensation, for example, by seeking to direct more profitable investments to
clients that are subject to more lucrative compensation arrangements with the Firm or its affiliates.
However, the Firm’s Code of Ethics (the “Code”) prohibits the allocation of investment
opportunities based on anticipated compensation or profits to the Firm or its affiliates. For a
discussion of potential conflicts of interest that may exist, please see Items 8 and 11 below.

ITEM 7. TYPES OF CLIENTS

As further described in Item 4 of this Brochure, the Firm provides investment management
services to private Funds that the Firm operates in reliance upon the exclusion from the definition
of an “investment company” described in Sections 3(c)(1) and 3(c)(7) of the Investment
Company Act of 1940, as amended (the “Investment Company Act”). Investors in Client
accounts, including SMAs, represent a variety of institutional investors, high net worth
individuals and family offices.

Prospective Investors should refer to the Offering Documents of each respective Fund for
information on minimum investment requirements. The General Partner maintains discretion to
individually waive, increase or reduce the minimum investment required for both private Funds
and SMA accounts.